A highly sought after accredited virtual course delivered by world-renowned experts at Moorfields Eye Hospital, UCL Institute of Ophthalmology and the International Society for Clinical Electrophysiology of Vision (ISCEV).
This course will feature live lectures by an international faculty, interactive question and answer sessions and case discussions. Pre-recorded introductory lectures will cover topics such as anatomy, ophthalmic imaging and the clinical characteristics of genetic and acquired eye disease. Additionally there will be talks on pre-clinical and veterinary visual electrophysiology.
The course begins on Tuesday 31st August 2021 and will be available on-line until Sunday 31st October 2021. Please click here to download the programme timetable, which indicates which sessions are pre-recorded and which are live.
Please note that all live sessions have also been pre-recorded so that it remains possible to participate in the course regardless of time zone and also to begin the course after the live lectures have taken place.
The course is intended for clinicians who wish to practice in the field or expand their knowledge, to basic and clinical scientists and other paramedics who have an interest in clinical vision science and to technicians and clinical physiologists working in ophthalmological or neurological electrodiagnostic units.
The main course will include live lectures on the theory, practice and clinical and pre-clinical applications of visual electrophysiology. There will be lectures on electroretinography (ERG), pattern ERG, multifocal ERG, cortical visual evoked potential (VEP) and extended ERG protocols. Topics will be addressed in the context of clinical applications, including specialised paediatric techniques, in a wide range of retinal and visual pathway disorders.
To understand the theory and practice of electrodiagnostic testing.
To understand the diagnostic and clinical applications of different electrophysiological techniques including the full-field ERG, multifocal ERG, pattern ERG, EOG, VEP and ISCEV-extended protocols.
To interpret electrophysiological recordings in cases of inherited and acquired visual pathway and retinal disease.
To understand structure-function and genotype-phenotype correlations.
To understand the diagnostic value of electrophysiology in clinical practice.
To understand the role and practice of visual electrophysiology in basic science and pre-clinical applications
This course has been awarded 11 CPD points from the Royal College of Ophthalmologists and a certificate of attendance will be awarded at the end of the course.
In order to access the programme online, you will need access to a computer (laptop or desktop) with a webcam and microphone. You will also need access to a free zoom account and a stable broadband connection. We also strongly recommend that you access the programme in a quiet environment.
Course Organiser: Dr Anthony G. Robson (Moorfields Eye Hospital/UCL).
Co-organisers: Dr Dorothy Thompson (ISCEV); Dr Magella Neveu (Moorfields Eye Hospital), Dr Suresh Viswanathan (ISCEV).
Faculty includes: Dr Rola Ba-Abbad, Prof. Michael Bach, Dr Antonio Calcagni, Dr Ruth Hamilton, Prof Michael Hoffmann, Prof. Bart LeRoy, Dr Omar Mahroo, Dr Magella Neveu, Dr Anthony Robson, Dr Dorothy Thompson, Dr Patrick Yu Wai Man. Dr Mitch Brigell, Dr Bang Bui, Prof Mineo Kondo, Dr Prof Bo Lei, Prof Mathias Seeliger, Dr Suresh Viswanathan.
A 33% discount is available for ISCEV members - please email email@example.com to receive a voucher code.
This course exceeded my expectations. Very professional approach and lots of useful practical information. I had heard that the Moorfields electrophysiology course is very good but it is excellent!
2020 course attendee
Anthony has worked in Clinical Neurophysiology and Visual Electrophysiology for more than 30 years, including the last 16 years as a Consultant Electrophysiologist at Moorfields Eye Hospital and Honorary Associate Professor at the UCL Institute of Ophthalmology, London. He currently leads one of the largest Electrophysiology Departments worldwide and has written or co-authored more than 170 peer-reviewed publications, mainly on clinical visual electrophysiology and genotype-phenotype correlations. He was elected to the Macula Society (U.S.) in 2011, was awarded the position of Honorary Professor at the Southwest Hospital Medical University, Chongqing, China, in March 2017 and is the current Director of Standards for the International Society for Clinical Electrophysiology of Vision.
Bart is an ophthalmologist and clinical geneticist specialised in inherited eye disorders. He was part of the team that developed the first certified gene therapy for RPE65-related inherited retinal blindness (voretigene neparvovec). Bart is Full Professor of Ophthalmology, Ophthalmic Genetics and Visual Electrophysiology at Ghent University and a board member of the International Society of Genetic Eye Disease & Retinoblastoma (ISGEDR).
Dr Ba-Abbad is a Consultant Ophthalmologist, specialised in inherited retinal disorders for adults and children, and medical retina at King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia, and Moorfields Eye Hospital Dubai, UAE. She has undertaken research in inherited retinal disorders, visual neuroscience-clinical psychophysics, and electrophysiology of vision and has published several research papers in leading journals such as Ophthalmology and Investigative Ophthalmology and Visual Sciences, among others.
Antonio currently works as a Consultant Electrophysiologist at Moorfields Eye Hospital and holds honorary positions at the University of Birmingham and Aston University. He gained his MD defending the thesis “Iris Pigmentation and Normal Contrast Sensitivity” and then went on to do his Ophthalmology training in the West Midlands and Oxford Deaneries in the UK. He is a Board member of the British Society for Clinical Electrophysiology of Vision (BriSCEV) and member of the Midland Ophthalmological Society.
Michael Bach studied Physics, Computer Science and Psychology. His PhD work at the University of Freiburg, Germany dealt with single- and multiunit neuron recordings in animal models. He has 290+ peer-reviewed papers and has authored several computer systems for electrophysiology, a widely used computer-based vision test (“FrACT”).He is a receipient of the prestigious “von Graefe Award”. Now Professor emeritus, he serves ISCEV as Director of International communications.
Mineo is Chair of the Department of Ophthalmology at the Mie University Graduate School of Medicine. With more than 200 peer-reviewed publications, Professor Kondo currently serves on the editorial boards of four scientific journals: Translational Vision Science and Technology, Documenta Ophthalmologica, Current Eye Research, and Japanese Journal of Ophthalmology. He was also elected to the Macula Society Member, and Board Member of ISCEV.
Dr Yu-Wai-Man is an academic neuro-ophthalmologist with a major research interest in mitochondrial genetics and inherited eye diseases. His research programme is currently focused on dissecting the disease mechanisms leading to progressive retinal ganglion cell loss in mitochondrial optic neuropathies. Dr Yu-Wai-Man has built a national referral network for the investigation and management of patients with mitochondrial eye diseases. Dr Yu-Wai-Man is a Council member of the European Neuro-Ophthalmological Society (EUNOS) and he sits on a number of national and international committees (NANOS, JNO, ARVO, EVER)
Ruth is a Consultant Clinical Scientist in paediatric physiological measurement at the Royal Hospital for Children in Glasgow, UK. She runs the paediatric visual electrophysiology service and also works across audiology, neurology, respiratory, ENT and neonatal services. She is a Board member of BriSCEV and President of ISCEV. Her main research areas are pre- and peri-natal influences on children’s vision, reference data, patient-friendly visual electrophysiology, digital vision tests and tele-ophthalmology.
Magella is a Consultant Clinical Scientist and the Operations Manager in the Electrophysiology Department at Moorfields Eye Hospital, London. She is the Lead Healthcare Scientist (HCS) and the Training Officer for the Scientist Training Programme (STP) at the trust. She is an Honorary Lecturer at the UCL Institute of Ophthalmology, London and a member of the North Central London Healthcare Science Council. She was awarded a Long Service Award for 20 years of service at Moorfields Eye Hospital NHS Foundation Trust in 2018.
Omar Mahroo is a consultant ophthalmologist and retinal specialist at Moorfields Eye Hospital and St Thomas’ Hospital, managing patients with inherited retinal disease. He is also Professor of Retinal Neuroscience at University College London. He completed his medical degree and PhD at the University of Cambridge in 2004. His PhD at Cambridge and his post-doctoral work at the Australian National University (both under the supervision of Trevor Lamb FRS) investigated light and dark adaptation of human retinal photoreceptors and bipolar cells in vivo using the electroretinogram. He completed his ophthalmology training in the London Deanery. He was appointed Academic Clinical Lecturer at King’s College London in 2011, setting up an electroretinogram research laboratory at St Thomas’ Hospital in 2012, investigating heritability and age-related changes in retinal responses in the TwinsUK cohort, and also retinal mechanisms driving myopia. He completed a retinal fellowship at Moorfields Eye Hospital (2014-16). He was awarded a £1.1 million Wellcome Trust research fellowship in 2017 to investigate retinal mechanisms in health and disease and is Principal Investigator for a number of studies. He was named “Rising Star of the Year” by the Macular Society in 2019, and received awards for teaching excellence and for patient and public engagement from the UCL Institute of Ophthalmology and the Moorfields Biomedical Research Centre in 2020. He has co-authored numerous publications (including in the New England Journal of Medicine, Nature Genetics, Ophthalmology, Brain) and book chapters. He has lectured on the Moorfields Electrophysiology Course since 2018
Dorothy is a Consultant Clinical Scientist specialising in Paediatric Visual Electrophysiology at Great Ormond Street Hospital for Children in London UK where she is director of the Tony Kriss Visual Electrophysiology Unit. She has been ISCEV Director of Education since 2014 and thoroughly enjoys working with and learning from many talented educators across the globe. Dorothy is Chair of BriSCEV, the UK professional body for visual electrophysiology, which has helped establish a UK training programme in Ophthalmic Vision Sciences for visual electrophysiology.
Michael is biologist trained at Univ’s. Münster, Tübingen, Sussex, Freiburg, Royal Holloway London. Since 2004 he is head of the Section for Clinial and Experimental Sensory Physiology at the Ophthalmic Department at Magdeburg University. He is responsible for diagnostics and research on physiology, pathophysiology, and plasticity of the human visual system with a combined approach of non-invasive electrophysiology, psychophysics and various retinal and brain imaging techniques. He is training coordinator in several Horizon2020-funded European innovative training networks, reviewer for many scientific journals and funding bodies, and recipient of the ‘Elfriede-Aulhorn award’ for outstanding research in neuro-ophthalmology.
Bo Lei, MD, PhD, FARVO, received his MD in Zhengzhou University and PhD in Technion-Israel Institute of Technology. He was a post-doctoral fellow in the University of Michigan, Ann Arbor and an assistant professor in the University of Missouri. He serves a professor and the deputy director of Henan Eye Institute and the director of National Clinical Research Center for Ocular Disease Henan Branch. Dr. Lei is focused on clinical and translational research in inherited retinal diseases. He has conducted researches in electroretinography and gene therapy for retinal degenerations. He has published 86 peer reviewed papers.
Bang completed his Masters and PhD in visual neuroscience in 2003, at the University of Melbourne. Upon completion of his PhD he was awarded an NHMRC CJ Martin fellowship to undertake studies into the pathogenesis of glaucoma at the Devers Eye Institute in Portland Oregon. He was recipient of an Australian Research Council Future Fellowship in 2014. He is currently deputy head of Department of Optometry and Vision Sciences at the University of Melbourne and his research group uses a range of pre-clincial models and well as clincial approaches focused on understanding the interactions between retinal vasculature, immune cells and neurons and the risk factors underlying neurodegenerative diseases including glaucoma and diabetes.
Laura is the Associate Dean for Graduate Studies and Research for the College of Optometry at the University of Houston, TX where she has taught in both the profession and graduate programs. Professor Frishman is on the editorial boards of Investigative Ophthalmology and Visual Science (IOVS), Translational Vision Science and Technology (TVST), and an academic editor for Plos One, She has served on US and international grant review panels, the NIH National Advisory Eye Council, and she is a fellow of the Association for Research in Vision and Ophthalmology (FARVO), American Academy of Optometry (FAAO) and a long time board member of the International Society for the Clinical Electrophysiology of Vision (ISCEV). Her research and publications have focused on clarifying the origins of components of the flash and multifocal ERG in animal models, and refining noninvasive electrophysiological approaches for evaluating inner retinal and anterior visual pathway function in normal subjects and subjects with inherited or acquired diseases that affect visual function.
Mineo is Chair of the Department of Ophthalmology at the Mie University Graduate School of Medicine. He is an active clinician scientist who has continuously published original experimental and clinical studies on the retina and macula. His special interest is the physiology of the retina in normal and diseased eyes, and he has used electrophysiological, morphological, and molecular biological techniques to diagnose and characterize eyes with retinal diseases. With more than 200 peer-reviewed publications, Professor Kondo currently serves on the editorial boards of five scientific journals: Translational Vision Science and Technology (Associate Editor), Documenta Ophthalmologica (Associate Editor), Current Eye Research, Graefes Archives of Clinical and Experimental Ophthalmology, Japanese Journal of Ophthalmology. He was also elected to the Macula Society Member, Retina Society Member, ARVO Gold Fellow, and Board Member of ISCEV.
For the past 20 years Dr. Brigell has worked in the pharmaceutical industry leading clinical development of agents for the treatment of ophthalmic diseases. He currently consults for a number of biotechs. Dr. Brigell was the Vice President of Clinical Development at Aerpio Pharmaceuticals from 2013 to 2019. While at Aerpio, Dr Brigell directed the development of a pipeline of novel small molecules and monoclonal antibodies for the treatment of diabetic retinopathy, glaucoma, wet AMD and DME. Before Aerpio, Dr. Brigell was Executive Director of Translational Medicine, Ophthalmology at Novartis Institutes of BioMedical Research and held roles of increasing responsibility at Parke-Davis/Pfizer in Experimental Medicine and Clinical Technologies. He originally joined the pharmaceutical industry as part of the Clinical Development team for Pregabalin (Lyrica). Dr. Brigell spent over a decade in academic medicine at Loyola University and the University of Chicago in the Departments of Neurology, Neuroscience and Ophthalmology. His area of academic interest focused on electrophysiological and behavioral effects of diseases of the retina and optic nerve. He has published over 70 scientific papers and is a Fellow of the Association of Research in Vision and Ophthalmology. Dr. Brigell is on the Editorial Board of Translational Vision Science and Technology and Documenta Ophthalmologica.
Neal Peachey graduated from Hobart College (Geneva NY) in 1978 and received his PhD in Experimental Psychology at Northeastern University (Boston MA) in 1985. After post-doctoral training in the Ophthalmology Department of the University of Illinois at Chicago (Chicago IL) he joined the Department of Neurology at Loyola University Medical Center (Maywood IL) and established a vision research laboratory at Edward J. Hines VA Hospital (Hines IL). In 2000 he relocated to Cleveland to join the newly established Cole Eye Institute of the Cleveland Clinic and the Cleveland VA Medical Center. He is currently Professor of Ophthalmology of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and Associate Chief of Staff for Research at the Cleveland VA Medical Center.
Suresh Viswanathan is a professor at the State University of New York College of Optometry where he also serves as Chair of the Department of Biological and Vision Science and Director of Institutional Research and planning. He also holds an appointment in Graduate Center for Vision Research at the college. Dr. Viswanathan’s research deals with early detection and monitoring of retinal ganglion cell dysfunction in glaucoma, traumatic brain injury and diabetes. He also explores the mechanistic underpinnings of visual symptoms in these conditions. His current work is supported by funding from the US Department of Defense and the National Eye Institute. Dr. Viswanathan is a member of the board of directors of the International Society of Clinical Electrophysiology of Vision (ISCEV) and is an associate editor of Documenta Ophthalmologica, the official journal of ISCEV. He also holds membership and committee responsibilities in multiple professional organizations including the Association for Research in Vision and Ophthalmology, American Academy of Optometry, American Academy of Optometry Foundation, Optometric Glaucoma Society, Association of Schools and College of Optometry, and the American Optometric Association.
Myers-Dunlap Chair in Canine Health, Michigan State University. USA
Simon Petersen-Jones is a veterinary ophthalmologist with an interest in the study and treatment of retinal dystrophies in companion animals. His veterinary degree and veterinary ophthalmology residency training were completed at the Royal Veterinary College, London. He completed a PhD at University of Cambridge before moving to Michigan State University. His lab is currently working to identify the causal gene mutations for several retinal dystrophies in dogs and cats and developing translational gene therapy for those that are good models for human inherited retinal degenerations.